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m109775 TEEfor CardiovascularSourcsof Emboli:Determinationof PreteatProbabilityUsingITE
andPresenceofAtrialFibrillation
A. Shiran, S.A. Goldstein, S. Ellahham, P.Sears-Rogan, E. Pinnow,
J. Lindsay, Jr.. Washington Hospital Cerrteri kVasfrirrgton,DC, USA
Although TEE infrequently done In pts with suspected cardiovascular source
of emboli (CSE) the yield in unselected pts is unclear. There is also con-
troversy regarding anticoagulation for some of the findings such as patent
foremen ovale (PFO), atrial septal aneurysm (ASA) and spontaneous echo
contrast (SEC). We speculated that the yield of TEE could be predicted
from TTE and the presence/absence of atrial fibrillation (AF). We studied all
patients who had l_TE and TEE at our hospital for evaluation of CSE (226
pta, age 57 + 15, 111 men, 115 women). In 41 pts with AF, EF < 30% or
definite thrombus or vegetation (veg) on TTE, TEE was considered unlikely
to influence management. The remaining 185 pts were then classified as low
pretest probability (PP) if they had adequate quality TEE, LA size c 5 cm, no
mitral stenosis, EF 2 30Y0, no prosthetic valves, no suspicion of thrombus
or veg on TTE and no AF (n = 113). otherwise pts were classified as high
PP (n = 72). TEE findings were classified as probable CSE (thrombus, veg,
mobile atheroma in ascending aorta or arch) or possible CSE (PFO/ASD,
ASA, SEC, non mobile atheroma or suspected thrombus orvegetstion):
Nagative TEE PossibleCSE ProbsbleCSE p value”
Low PP (n = 113) 71 (63°,6) 39 (35%) 3 (2.7”A) 0.02
HighPP(n = 72) 46 (64”/.) 17 (24%) 9 (134A)
PFO/ASD wee present in 31/39 (79%) low PP/possible CSE pts.
Conclusion: 1) TTE and AF can be used to determine preteet probability
for finding a probable CSE on TEE. 2) TEE might have been avoidad in the
majority of patients, thereby increasing cost effeotivenese of TEE.
m109776 NonRheumaticAtrialFibrillationandLeftAtrialThrombuaFormation-Relationbetweenleftatrial
appendagefunction,clinicalandhaematological
findings
S. Scardi, C. Mazzone, C. Pandullo, D. Goldstein, C. Giansante, N. Fiotti 1.
Centro Cardiovsscolare Ospedale Maggiore, Italy 1Istituto di Clinics
Medics, Italy, University di Trieste, Italy
The mechanisms of left atrial thrombus (lAT) formation in patients (P) with
nonrheumatic atrial fibrillation (NRAF) have not been yet fully understood.
However It is likely that hemostatic abnormalities, blood stasis within the left
atrium (LA) and chamber wall alteration are conditions which predispose to
thrombus formation (UT).
Trfeste Area Study on NRAF enrolled 694 consecutive P with NRAF;
during tha follow up in 77 P (44 males) we determined Fibrinogen (FR), D-
Dimer (D) and FPA immediately before Transesophageal Echocardiography
(TEE). These data were compared with 117controls extracted from a normal
population community sample.
LAT was found in 27 P (35%), spontanecua achocontraet (SEC) in 14P
(16%).
Presence of IAT No LAT Controls P
27 P (35°/6) 50P (a50AJ 117P
DurationAF 129 i Iol’months 62+ 55 months - 0.04
SEC 10P (37”/0) 4 P (6”/0) 0.02
Low LAAV 59P (77%) 2 P (3)
FR (mg/dl)
0.00001
335 + f06* 270 + 100* 236 & 71* 0.05”
D (ng/dl) 436 + 271* 315 * 212* 306 + 271* 0.01”
FPA (ngrdl) S.6 & 6.2* 2.4 & 0.4” 2.0 * 0,4” 0.001”
“Legend:*p between groups,LAAV:left atrialappendsgevelmity flow
Conclusions: P with LAT had high prevalence of SEC, low velocity in the
LAA. FPA plasma levels, D and FR are significantly higher in P with LAT
than in the other groups. Our date demonstrate a close correlation between
hematologial and IAA flow data in the genesis of LAT.
Moreover FPAand D levels can ba useful in identifyitig P at higher risk of
LAT.
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m1098155 V02 PlataauandExertionalDyspneain Patiente
withRegurgitantValvularHeartDisease
T. Hasuda, Y. Okano, T. Yoshioka, S. Kyotani, T. Satoh, N. Nakeniehi,
H. Takaki, Y. Goto. Nationa/ Cardiovascular Cerrtec Siuta, Osaka, Japan
Background: Exertional dyspnea is a frequent limiting symptoma in patients
(pts) with chronic heart failure (CHF). Although VOZ plateau was often found
in CHF, especially in thoae with severe regurgitant valvular heart disease
(RVHD), its relevance to hemodynamica and subjective symptoms during
exercise have not been fully understood. Method and Results: We per-
formed a symptom-limited cardiopulmonary exercise (EX) test using a sitting
cycle ergometer with right heart catheterization in 20 pts with moderate to
severe aortic or mitral RVHD. Oxygen uptake (VOZ) and hemodynamica
were measured at rest and during EX, symptomatic end-point at the peak EX
was evaluated by Borg’s score. 11 of 20 pte attained VOZ plateau at peak
EX (Group 1). At peak EX, pulmonaty arterial pressure (PAP), cardiac out-
put (CO) and VOZ were significantly different in Group 1 compared with pts
without VOZ plateau (Group 2) (table 1), although systemic arterial presaure
and heart rate were not different. In group 1, 6 pts complaining of dyspnea
more than leg fatigue (G1-D) at peak Ex had lower CO and higher slope of
mean PAP-COrelation (P-Q slope) compared with other 5 pts with leg fatigue
(GI-L) (table 2). Conclusion: Development of PH (pulmonary hypertension)
during EX is the important limiting factor of Ex capacity in pts with RVHD and
the limitation of increase in COconcomitant with PH could be more important
faotorfor appearance of dyspnea.
Table 1
G1 (n= 11) G2 (n = 9) P
Mean PAP (mmHg) 60+ 10 4s * 9 0.05
CO (!lmin) S.3 k 2.6 11.2 + 2.6 0.01
VOZ (m!lmin) 1059 + 259 135S+ 32S 0.01
Tabla2
G1-D (n = 6) GI-L (n = 5) P
Mean PAP 66* 14 53* 20 NS
co 7.1 * 1.s 9.7+ 3.0 0.05
P-Q alope 10.6 + 3.6 5.4 i 1.7 0.01
m1098156 MetabolicAbnormalityof CalfSkeletalMuscleIsImprovedby LocalizedMuscleTraining
Independentof BloodFlowin ChronicHeart
Failure
M. Ohtsubo, K. Yonezawa, K. Okita, A. Hanada, T. Kohya, H. Nishijima,
A. Kitebatak6. Hokkaido University Schoo/ of Medicina, Sapporo, Japan
Patients with chronic heart failure (CHF) are often limited in daily activities
due to leg fatigue. Abnormal akeletal muscle metabolism may contribute to
patients’ symptom. However, no reperk have been made for localized lag
muscle training. Therefore, we investigated whether kmalized calf muecle
training improved its abnormalities in CHF. Seven patients with New York
Heart Association class II were investigated. The study was designed se
a random-order and crossover comparison of combined phasea of 8-week
training and 6-week detraining. Right calf muscle was trainad uaing plan-
tarflexion. At baseline and after each phase, patients were examined for
metabolic response with phosphorus-31 magnetic resonance spectroaoopy
and calf blood flow with plethysmography during calf plantarflexion exer-
cise. The test coneistad of constant-load exercise. The new Borg scale wae
also chacked. After training, the decrease of standardized PCr and intracel-
lular pH were less, but blood flow did not change significantly. New Borg
score improved significantly after training (p c 0.03). In conclusion, localized
calf muscle training improved oxidative capacity independent of blood flow in
CHF.This training program also improved fatigue score. Localized calf skela-
tal muscle training may improve symptoms associated with daily activities in
CHF.
